+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The role of kidney biopsy to determine donation from prospective kidney donors with asymptomatic urinary abnormalities



The role of kidney biopsy to determine donation from prospective kidney donors with asymptomatic urinary abnormalities



Transplantation Proceedings 44(1): 11-13



There are no definite guidelines about donation among prospective donors with asymptomatic urinary abnormalities. We evaluated the pathology of prospective kidney donors with asymptomatic urinary abnormalities and assessed the clinical outcomes of their organs. We reviewed the medical records of 15 prospective kidney donors who underwent kidney biopsy. We evaluated the role of kidney biopsy in terms of graft function, protocol biopsy, and follow-up biopsy. We further assessed the clinical outcomes of donors and recipients. Thin basement membrane nephropathy (TBMN) is the most common cause of the persistent microscopic hematuria (n = 7; 50%), followed by nonspecific findings (n = 4; 29%), IgA nephropathy (n = 2; 14%), and focal segmental glomerulosclerosis (n = 1; 7%). Of the 14 candidate donors with persistent microscopic hematuria, 9 were accepted as kidney donors: 5 with TBMN, 3 with mild mesangiopathy, and 1 with nonspecific interstitial changes. The function of the 9 grafts was relatively stable (mean serum creatinine level 2.38 mg/dL) over a mean follow-up of 57 months. Graft failure that developed in 2 grafts was not associated with biopsy findings: acute rejection and patient death with a functioning graft. Interestingly, basement membrane thickness in 2 allografts from donors with TBMN appeared normal by electron microscopy follow-up biopsy; the allografts did not show hematuria. Moreover, the clinical outcomes of donors were favorable (mean serum creatinine 0.94 ± 0.32 mg/dL) during the mean follow-up period of 34.7 ± 42.5 months. We did not observe new-onset hypertension or proteinuria in donors. Kidney biopsy in prospective kidney donors with urinary abnormalities is a safe and effective diagnostic procedure to stratify candidates. Therefore, kidney biopsy should be actively performed to improve the prognosis of both donors and recipients.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036335723

Download citation: RISBibTeXText

PMID: 22310565

DOI: 10.1016/j.transproceed.2011.12.008


Related references

Accepting prospective kidney donors with asymptomatic urinary abnormalities: are we shooting in the dark?. Kidney International 71(2): 173-177, 2006

Living kidney donors – a prospective study of quality of life before and after kidney donation. Clinical Transplantation aop(aop), 2012

Living kidney donors--a prospective study of quality of life before and after kidney donation. Clinical Transplantation 27(1): 9-14, 2013

Analysis of preexisting baseline kidney lesions revealed by biopsy in living kidney donors: relationship with clinical parameters at the time of donation. Clinical Transplantation 24 Suppl 22: 27-30, 2010

Investigating kidney donation as a risk factor for hypertension and microalbuminuria: findings from the Swiss prospective follow-up of living kidney donors. Bmj Open 6(3): E010869, 2016

Influence of the kidney histology at the time of donation on long term kidney function in living kidney donors. Transplantation Proceedings 37(8): 3351-3353, 2005

Do multiple renal arteries in the remnant kidney have a negative influence on kidney donors after kidney donation?. Nephrology 16(6): 612-616, 2011

Pre- and postdonation kidney function in donors of a kidney paired donation with unique criteria for donor glomerular filtration rate - a longitudinal cohort analysis. Transplant International 2018, 2018

The science of Stewardship: due diligence for kidney donors and kidney function in living kidney donation--evaluation, determinants, and implications for outcomes. Clinical Journal of the American Society of Nephrology 4(10): 1677-1684, 2010

Very low but stable glomerular filtration rate after living kidney donation: is the concept of "chronic kidney disease" applicable to kidney donors?. Clinical and Experimental Nephrology 14(4): 356-362, 2010

Recognition of Kidney Donation by Living Kidney Donors That Accompanies Changes in the Recipients' Physical Condition: Focusing on Its Influences on Donors. Transplantation Proceedings 49(5): 944-949, 2018

Prospective assessment of urinary neutrophil gelatinase-associated lipoprotein in living kidney donors: toward understanding differences between chronic kidney diseases of surgical and medical origin. Bju International 2018, 2018

Histopathologic Findings of Potential Kidney Donors With Asymptomatic Microscopic Hematuria: Impact on Donation. Transplantation Proceedings 49(8): 1729-1732, 2018

Standardized deceased donor kidney donation rates in the UK reveal marked regional variation and highlight the potential for increasing kidney donation: a prospective cohort study†. British Journal of Anaesthesia 113(1): 83-90, 2014

Long-term Renal Function in Living Kidney Donors Who Had Histological Abnormalities at Donation. Transplantation 100(6): 1294-1298, 2017